Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Yuki Isogai"'
Autor:
Noboru Imai, Yuki Isogai, Yoshiyuki Shibasaki, Masami Nakai, Miki Ishida, Xiaoping Ning, Nobuyuki Koga
Publikováno v:
Neurology and Therapy, Vol 12, Iss 6, Pp 1981-1991 (2023)
Abstract Introduction Chronic migraine (CM) patients commonly take acute headache medications, often resulting in medication overuse (MO). This post hoc analysis evaluated the efficacy of fremanezumab in CM patients from Japan with and without MO, wh
Externí odkaz:
https://doaj.org/article/e5a4e02d0e424237a6a82a624ce122ed
Publikováno v:
AIP Advances, Vol 9, Iss 10, Pp 105219-105219-5 (2019)
A reactive-plasma deposition (RPD) process damage is evaluated for an indium-tin-oxide (ITO)/SiO2/Si structure in terms of the recombination properties at the interface. To calculate the surface recombination velocity (SRV), the defect density at the
Externí odkaz:
https://doaj.org/article/30816bdf561542c0a2ee4f3046c74436
Autor:
Kazumasa Saigoh, Takao Takeshima, Masami Nakai, Yoshiyuki Shibasaki, Miki Ishida, Xiaoping Ning, Steve Barash, Yuki Isogai, Nobuyuki Koga
Publikováno v:
Journal of Pain Research.
Kazumasa Saigoh,1 Takao Takeshima,2 Masami Nakai,3 Yoshiyuki Shibasaki,4 Miki Ishida,5 Xiaoping Ning,6 Steve Barash,6 Yuki Isogai,4 Nobuyuki Koga7 1Department of Neurology, Kindai University School of Medicine, Osaka, Japan; 2Headache Center, Departm
Autor:
Yuki Isogai, Miki Ishida, Fumihiko Sakai, Chiharu Usuki, Norihiro Suzuki, Xiaoping Ning, Nobuyuki Koga, Katsuhiro Iba
Publikováno v:
Drug Safety
Introduction Early discontinuation and poor adherence are common limitations of conventional preventive migraine medications that limit their long-term efficacy. Therefore, a migraine preventive medication with favorable long-term safety is warranted
Autor:
Kazuhito Nakagawa, Tomohiko Hara, Takefumi Kamioka, Taichi Tanaka, Yuki Isogai, Yoshio Ohshita
Publikováno v:
Electronic Materials Letters. 17:399-405
Effect of lights with various wavelength on the defect generation in reactive plasma deposition (RPD) process is studied using capacitance–voltage analysis. Indium-tin oxide (ITO) deposition by RPD dramatically decreases the minority carrier lifeti
Autor:
Atsushi Ogura, Yutaka Hayashi, Yoshio Ohshita, Takefumi Kamioka, Kyotaro Nakamura, Yuki Isogai
Publikováno v:
2018 IEEE 7th World Conference on Photovoltaic Energy Conversion (WCPEC) (A Joint Conference of 45th IEEE PVSC, 28th PVSEC & 34th EU PVSEC).
Effects of an ITO capping layer on the interface workfuncion of MoO x was studied for an ITO/MoO x /SiO2/Si structure device from the viewpoint of the behavior of In atoms. The workfunction of MoO x at the MoO x /SiO 2 interface, which were extracted
Publikováno v:
Extended Abstracts of the 2017 International Conference on Solid State Devices and Materials.
Autor:
Hiroyasu Sato, Tetsuya Hirabayashi, Yuki Isogai, Michael H. Gelb, Tetsuyuki Kobayashi, Yuichi Oike, Kei Yamamoto, Takumi Kojima, Yasumasa Nishito, Yoshitaka Taketomi, Shuntaro Hara, Satoshi Ida, Yuji Miyamoto, Ayako Ushida, Yoshimi Miki, Makoto Murakami, Masayuki Watanabe, Ryo Taguchi, Hideo Baba, Keishi Miyata, Kazutaka Ikeda
Publikováno v:
Cell Metabolism. 20:119-132
Metabolic disorders including obesity and insulin resistance have their basis in dysregulated lipid metabolism and low-grade inflammation. In a microarray search of unique lipase-related genes whose expressions are associated with obesity, we found t
Publikováno v:
AIP Advances, Vol 9, Iss 10, Pp 105219-105219-5 (2019)
A reactive-plasma deposition (RPD) process damage is evaluated for an indium-tin-oxide (ITO)/SiO2/Si structure in terms of the recombination properties at the interface. To calculate the surface recombination velocity (SRV), the defect density at the
Autor:
Yoshikazu Ishimoto, Yuki Isogai, Kohji Hanasaki, Shuntaro Hara, Makoto Murakami, Noriko Suzuki, Yoshitaka Taketomi, Yukio Ishikawa, Seiko Masuda, Yasunori Yokota, Kazutaka Ikeda, Hiroyasu Sato, Kei Yamamoto, Yoshimi Miki, Daisuke Kamei, Toshiharu Ishii, Ryo Taguchi, Toshiko Suzuki-Yamamoto, Tetsuyuki Kobayashi
Publikováno v:
Journal of Biological Chemistry. 286:11632-11648
Although the secreted phospholipase A(2) (sPLA(2)) family has been generally thought to participate in pathologic events such as inflammation and atherosclerosis, relatively high and constitutive expression of group X sPLA(2) (sPLA(2)-X) in restricte